Highlights
-
•
Streptococcus agalactiae is an emerging environmental pathogen in the aquatic environment.
-
•
Monoclonal antibodies were generated against bottlenose dolphin IgG and against spotted eagle ray and bull shark IgG.
-
•
A previously generated monoclonal antibody against loggerhead sea turtle IgY was used to compare marine vertebrate responses.
-
•
Relative antibody titers against S. agalactiae were quantified and compared to calculated antibody activities.
-
•
Calculated antibody activities are more sensitive than simply relative antibody titer data.
Keywords: Bull shark IgM, Spotted eagle ray IgM, Bottlenose dolphin IgG, Loggerhead turtle IgY, Streptococcus agalactiae, mAb, Oceans human health
Abstract
Global Streptococcus agalactiae and related pathogen infections are increasing, and place both wildlife species and humans at risk. Notably, Streptococcus agalactiae is now considered to be an emerging and zoonotic pathogen. Mouse monoclonal antibodies (mAbs) were generated against bull shark, Carcharhinus leucas, and spotted eagle ray, Aetobatus narinari, IgM, and bottlenose dolphin, Tursiops truncatus, IgG. Along with a previously generated mAb against loggerhead, Caretta caretta, IgY, these biological reagents were used to compare the sensitivity of relative antibody titers at sample dilutions of 1:200 in buffer to calculated antibody activities against whole cell Streptococcus agalactiae in wild captured individuals. Robust antibody responses were observed in each species, though some individuals differed significantly depending on whether viewed as relative antibody titers at sample dilutions of 1:200 or as antibody activities. The data from this study indicate that calculated antibody activities are more informative than relative antibody titers in determining antibody responses despite being more labor-intensive, expensive, and time consuming. This study provides several novel antibody reagents to the greater community of comparative immunologists, with a particular application to monitoring sentinel species for exposure to new emerging and zoonotic pathogens.
In this study our goal was to develop monoclonal antibodies (mAbs) against bull shark, Carcharhinus leucas, and spotted eagle ray, Aetobatus narinari, immunoglobulin (Ig) M (IgM), bottlenose dolphin, Tursiops truncatus, IgG, and, along with a previously described mAb against loggerhead sea turtle IgY, compare relative antibody titers to activities against an aquatic strain of Streptococcus agalactiae, an emerging environmental pathogen [1], [2], [3]. Streptococcus agalactiae (group B streptococcus) is a Gram-positive bacterial pathogen known to cause septicemia, necrotizing fasciitis, and large mortality events in a variety of aquatic organisms. For example, this bacterium is known to affect crocodiles, frogs, and an array of bony fish species [4], [5], [6], [7], [8], [9] and elasmobranchs [10,11]. In humans and bovines, it is known to cause neonatal meningitis and mastitis, respectively [12,13]. Streptococcus agalactiae has also been isolated from both captive and wild bottlenose dolphins [1,14,15]. Due to its ability to adapt and survive in a wide variety of environments, more outbreaks of Streptococcus agalactiae are likely to occur in the aquatic environment as the main route of exposure is from the ingestion of streptococcal contaminated materials [1,16,17]. In addition, outbreaks could have implications for humans and aquatic species as some studies suggest that disease associated with this pathogen may be caused by the same or similar strains of S. agalactiae [1,9,18,19].
Bull Sharks (n = 10) and Spotted Eagle Rays (n = 8) were captured as part of a fishery-independent survey in the Indian River Lagoon (IRL) between Brevard and Martin Counties of Florida USA between 2017 and 2019 [20]. A blood sample (<1% of body weight) was collected from each individual via caudal vein or wing vein (rays) puncture with an 18 or 20 gauge 1-1.5-inch needle connected to a 10 ml syringe and immediately transferred to a serum separator tube. Blood samples were centrifuged for 10 min at 1000 x g. Serum was then transferred to cryovials and stored at -80°C prior to shipping to Clemson University facilities. Bottlenose dolphin serum samples (n = 33) were randomly chosen from limited samples stored and used in previous studies [21], [22], [23], [24], [25], [26]. An in-hand monoclonal antibody (mAb LH-9) against loggerhead sea turtle IgY has been previously described with technical applications [27,28]. Serum samples (n = 9) from loggerhead turtles were randomly chosen from limited samples stored and previously used in other studies [29].
Procedures to purify IgM from bull shark and spotted eagle ray serum samples using Protein-A columns were previously described for the Atlantic sharpnose shark, Rhizoprionodon terraenovae, [30]. This approach was previously shown to be efficient for isolation of IgM from several species of fish, including elasmobranchs [30], [31], [32]. Due to the loss of previously generated hybridomas secreting mAbs against bottlenose dolphin IgG, it was necessary to generate another source using previously reported approaches [25]. Mouse mAbs were generated using routine procedures as described in previous studies from our lab [33,34]. Subsequent testing revealed that mAbs SER12-9, 4F8, and KA-6 were most suitable for spotted eagle ray, bull shark, and bottlenose dolphin immunoglobulin (Ig), respectively. Each of these three mAbs were found to be an IgG1 κ isotype. Purified Ig products from the two elasmobranchs and bottlenose dolphin were then subjected to SDS-PAGE under reducing conditions and immunoblotting using species-specific mAbs to verify specificity against targeted proteins of interest. We found that purified bottlenose IgG consists of the expected ≈ 55 kDa heavy chains and ≈ 25 kDa light chains (Fig. 1A). Under similar conditions purified spotted eagle ray and bull shark Ig consists of expected ≈ 75 -78 kDa heavy chains and ≈ 27 kDa light chains of IgM (Figure B, C). It is noted that the smaller Ig product is less abundant than the heavier Ig product for both elasmobranchs. This outcome was previously observed while purifying serum IgM from Atlantic sharpnose sharks wherein the heavier and lighter purification products were not equally abundant [30]. Such discrepancy in relative amount of heavy and light products of IgM upon protein-A purifications can also observed in bony fishes, depending on the species [31]. However, it is possible that we co-purified small amounts of IgNAR that may have degraded from the expected product [35,36]. Since IgNAR chains are not associated with light chains our heavier chains would be more brightly stained if in fact we co-purified small amounts of IgNAR. To explore these questions more thoroughly, future studies should immunoprecipitate whole serum proteins from spotted eagle rays and bull sharks with mAbs SER12-9 and 4F8, respectively, as described by Smith et al [37]. Our monoclonal antibody KA-6 is specific for the heavy chain of bottlenose dolphin IgG, and mAb SER12-9 and mAb 484 are specific to what appear to be the light chains of spotted eagle ray and bull shark IgM, respectively, though the light chains of IgW cannot be ruled out at this time. Also, we do not know at this time which light chain isotype(s) are recognized by mAbs SER12-9 and 484. Nonetheless, we have mAb reagents against purified Ig products that are specific to the lighter of two protein products revealed under reducing conditions (Fig. 1 B, C).
Fig. 1.
(A) SDS-PAGE and Coomassie blue staining of purified bottlenose dolphin IgG products, followed by Western blotting with mAb KA-6. Lane 1: molecular weight marker; Lane 2: purified IgG; lane 3; molecular weight standard; lane 4 immunoblot results showing recognition of 55 kDa heavy chain. (B) SDS-PAGE and Coomassie blue staining of purified spotted eagle ray Ig products, followed by Western blotting with mAb SER 12-9. Lane 1: molecular weight marker; Lane 2: purified Ig; lane 3; molecular weight standard; lane 4 immunoblot results showing recognition of 27 kDa product. (C) SDS-PAGE and Coomassie blue staining of purified bull shark Ig products, followed by Western blotting with mAb 484. Lane 1: molecular weight marker; Lane 2: purified Ig; lane 3; molecular weight standard; lane 4 immunoblot results showing recognition of 27 kDa product.
Streptococcus agalactiae cultures from an aquatic strain were a generous gift from Dr. John Hawke, Louisiana State University, and grown as directed [9]. High bonding 96 well plates (Corning, #9018) were coated for 16 h at 4°C with 75 µl of a 1 mg ml−1 solution of poly-D-lysine (VWR Scientific) in distilled water, followed by wash steps with phosphate buffered saline (0.01 M, pH 7.2) containing 0.05% tween-20 (PBS-TW20). To perform ELISAs against whole cell Streptococcus agalactiae cultures adhered to ELISA plates, cultures were first grown under conditions as previously described [29]. Optimized suspensions of live bacterium were then prepared and 50 µl of bacterium were added to wells using our lab's modifications [25,29,30] of the original developers of the assay [38], including fixation to the plates and subsequent blocking steps. To initiate assays, serum suspensions were made by adding 10 µl of serum from each individual animal into 990 µl of PBS-TW20 in 1.5 ml snap cap tubes to yield a dilution at 1:100. As a reference sample, a composite sample for each species comprised of serum from randomly selected individuals in PBS was made at a dilution of 1:100. Eighty µl of each diluted sample, including the composite reference sample, were added in duplicate to the respective wells and serially diluted to give 1:100, 1:200, 1:400, 1:800, and 1:1600 dilutions, followed by the addition of 40 µL PBS-TW20 to yield final dilutions of 1:200, 1:400, 1:800, 1:1600, and 1:3200. Each plate also contained two wells of 80 ul PBS-TW20 as an assay control. The plates were incubated overnight at 4°C and washed 4 times with PBS-TW.
As the source of mAb specific to each species, hybridoma supernatants from single batch confluent cultures were diluted 1:3 with hybridoma media containing 10% FBS [33] and 80 µl added to all wells of the plate and incubated at room temperature for 2 hr, followed by fours washes in PBS-TW. The remaining steps were routine and described elsewhere [29]. Goat anti-mouse IgG AP (1:2000) was added in 75 µL volumes to each well and incubated at room temperature for 1.5 h before being washed four times with PBS-TW20. Finally, 80 µL of 1 mg/mL p-nitrophenol phosphate (ThermoFisher) in AP buffer were added to each well, the plates were incubated for 30 min at room temperature, and the reaction was stopped with 100 ul 1M NaOH. Optical densities for all plates were read at 405 nm and the data recorded. Relative antibody titers were calculated as the optical density (O.D.) multiplied by the serum dilution factor of 1:200 [22,26,29,30]. Antibody activity for each sample was determined using previously published methods [39,40] and expressed as units of activity per µL serum. In brief, dilutions were expressed as the equivalent volume of the undiluted serum determined by taking the product of the volume of dilution used (75 ul) and each of the dilution factors. The standard curve was then used to determine volume of serum at the 50% point of the maximum O.D. obtained for the standard pooled serum, and this volume was then assumed to be the equivalent of one unit of antibody activity (1 Unit/volume of sample). Each sample was plotted against the 50% point of the maximum O.D. from the standard curve to determine the volume of test sample at that 50% point of the standard. To determine the activity for each of the test samples, the following equation was used: Activity of test sample = (activity of standard) x (50% volume of standard divided by 50% volume of test sample).
For statistical analysis, relative antibody titers from each species at a 1:200 dilutions were compared to their calculated activities using a Mann-Whitney U test. Correlations between individual relative titers at 1:200 dilutions and the same individual's antibody activity were determined by Spearman's correlation coefficient using GraphPad Prism9’s statistical software. An α-value of 0.05 was established prior to the study. When comparing how relative antibody titers and antibody activities are calculated it is generally expected that titers would be statistically higher than activities, and this was the case except for spotted eagle ray samples (Fig. 2). In general, relative titers were tightly clustered in bottlenose dolphin, loggerhead, and bull shark samples, while in spotted eagle ray samples half had very low titers while the other half were roughly 10 times higher. Interpreting the significance of this is difficult because the sample size is very low (n = 8), and this is due to the sparse distribution of these animals during the time of field work. While not examined in this study, it is possible that some of the rays were previously exposed to S. agalactiae and their immunoglobulin responses were higher relative to the unexposed. As noted, antibody titers in bull shark are tightly clustered even though the sample size is similar (n = 10) to what was available for spotted eagle rays. In this case it may be that all bull sharks sampled were previously exposed to S. agalactiae, or that their Ig (IgM?) is cross-reactive with similar antigens. Also, if our mAbs are in fact specific to IgM light chains, we do not know if the ELISA assays are recognizing pentameric IgM, monomeric IgM, or both. There is much to explore and learn about how spotted eagle rays and bull sharks respond to environmental pathogens under carefully controlled conditions, and especially how these responses compare to elasmobranch species such as the nurse shark and spiny dogfish that have been examined more thoroughly [35,37,41].
Fig. 2.
Comparison of relative antibody titers of serum or plasma dilutions at 1:200 and antibody activities (U/µl) for (A) bottlenose dolphins, n = 33, (B) loggerhead sea turtles, n = 9 (C) spotted eagle rays, n = 8 (D) bull sharks, n = 10. Significant differences between the mean relative titer and mean activities were found for bottlenose dolphins (A), loggerhead turtle (B), and bull shark (D). Spotted eagle relative titers and antibody activities did not differ (C). *** denotes p≤0.001; **** denotes p<0.0001.
Antibody activity data were much less clustered than relative titers. This variability is related to varying optical density values between samples as they are serially diluted, and thus some samples had higher signal levels at higher dilutions. In this view, it appears that antibody activity data are more sensitive and informative than relative titers in determining differences between samples. The highest available sample size was for bottlenose dolphins, and thus a large distribution of activities, ranging from 1.7 to 36 Units per μl sample (Fig. 2A). Activities in loggerhead samples ranged between 1.8 and 11.36 (Fig. 2B), between 5.7 and 57 for spotted eagle ray samples (Fig. 2C), and between 2 and 12.5 for bull shark samples (Fig. 2D).
One of the questions asked at the onset of this study is can relative antibody titers predict antibody activity in environmental species. This is important because calculating antibody activities is much more labor intensive, requires significantly more research consumables, and is far more time consuming. Only bull shark antibody activities correlated with relative titers (Fig. 3). If sample sizes were larger for spotted eagle rays, bull sharks, and loggerhead turtles, there may be a better correlation. Why the discrepancy between relative titers and activities in spotted eagle ray samples and the other species is currently unclear at this time.
Fig. 3.
Spearman correlation analysis between relative titers of serum or plasma dilutions at 1:200 to antibody activities (U/μl) in (A) bottlenose dolphins, n = 33, (B) loggerhead sea turtle, n = 9, (C) spotted eagle rays, n = 8, (D) bull sharks, n = 10. No significant correlations were found for relative antibody titers and antibody activities in bottlenose dolphins, loggerhead sea turtles, and spotted eagle rays. There was a positive correlation between relative antibody titers and antibody activities in bull sharks (*** denotes p ≤ 0.004).
Secondary to the development of these reagents we demonstrate that calculating antibody activities is a more sensitive and possibly more informative approach than calculating simple relative titers for quantifying antibody responses to pathogens of interest. This may be especially important when considering that the type of antibody responses in lower vs higher vertebrates is different in both kinetics and antibody class [41,42]. Serum elasmobranch pentameric IgM contains natural antibodies against a variety of carbohydrates, glycosylated proteins, and pathogen associated molecular patterns, leading to a high degree of cross-reactivity [35]. Moreover, elasmobranchs secrete pentameric IgM early in specific immune responses and then monomeric IgM as the response matures [43]. Reptiles such as sea turtles secrete IgY as their mature antibody response to environmental pathogens [27,29,44], while marine mammals, like humans, generate and secrete IgG as the mature Ig response to pathogens [25,45,46]. Going forward it will be important to compare Ig-class responses against various pathogens in terms of antibody activities. As reagents become available for anti-IgM and Ig-other classes within the same species investigators can develop ELISA assays to monitor Ig class-specific antibody responses in a variety of aquatic vertebrates. Towards this end, our mAbs are now available to the larger scientific community interested in the immunology of bottlenose dolphins, loggerhead sea turtles, spotted eagle rays, and bull sharks. These gregarious marine organisms may have a significant role in the reciprocal interactions between aquatic species, humans, and aquatic pathogens from an Oceans and Humans (OHH) perspective, and this topic has been extensively reviewed [47,48]. The broader OHH community links the effects of multiple interactions between biotic and abiotic factors to understand interspecies environmental health [49], [50], [51], [52] . These environmental interactions also include the likelihood of humans coming into contact with aquatic pathogens associated with known and emerging environmental pathogens typically contained within wildlife species [53]. Our reagents will be especially useful for those interested in these animals as sentinel species within the larger context of OHH.
Declaration of Competing Interest
We declare no conflicts of interest
Acknowledgements
Special thanks to Dr. Matthew J. Ajemian and the Fish Ecology and Conservation Lab at FAU Harbor Branch Oceanographic Institute. Funding for the collection of spotted eagle ray and shark samples was provided by the Disney Conservation Fund and the SeaWorld Bush Gardens Conservation Fund. Bottlenose dolphin serum samples were provided from multiple sampling periods under the Bottlenose Dolphin Health and Environmental Risk Assessment (HERA) Project funded by the Georgia Aquarium and the Florida Protect Wild Dolphins specialty license plate program.
References
- 1.Numberger D., Siebert U., Fulde M., Valentin-Weigand P. Streptococcal infections in marine mammals. Microorganisms. 2021;9(2):350. doi: 10.3390/microorganisms9020350. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Evans J.J., Bohnsack J.F., Klesius P.H., Whiting A.A., Garcia J.C., Shoemaker C.A., Takahashi S. Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. J. Med. Microbiol. 2008;57(Pt 11):1369–1376. doi: 10.1099/jmm.0.47815-0. [DOI] [PubMed] [Google Scholar]
- 3.Evans J.J., Klesius P.H., Pasnik D.J., Bohnsack J.F. Human Streptococcus agalactiae isolate in Nile tilapia (Oreochromis niloticus) Emerg. Infect. Dis. 2009;15(5):774–776. doi: 10.3201/eid1505.080222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Plumb J., Schachte J., Gaines J., Peltier W., Carroll B. Streptococcus sp. from marine fishes along the Alabama and northwest Florida coast of the Gulf of Mexico. Trans. Am. Fisheries Soc. 1974;103(2):358–361. [Google Scholar]
- 5.Amborski R., Snider T., Thune R., Culley D., Jr A non-hemolytic, group B Streptococcus infection of cultured bullfrogs, Rana catesbeiana, in Brazil. J. Wildl. Dis. 1983;19(3):180–184. doi: 10.7589/0090-3558-19.3.180. III. [DOI] [PubMed] [Google Scholar]
- 6.Bishop E., Shilton C., Benedict S., Kong F., Gilbert G., Gal D., Godoy D., Spratt B., Currie B. Necrotizing fasciitis in captive juvenile Crocodylus porosus caused by Streptococcus agalactiae: an outbreak and review of the animal and human literature. Epidemiol. Infect. 2007;135(08):1248–1255. doi: 10.1017/S0950268807008515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Bowater R.O., Forbes-Faulkner J., Anderson I.G., Condon K., Robinson B., Kong F., Gilbert G.L., Reynolds A., Hyland S., Mcpherson G., Brien J.O., Blyde D. Natural outbreak of Streptococcus agalactiae (GBS) infection in wild giant Queensland grouper, Epinephelus lanceolatus (Bloch), and other wild fish in northern Queensland, Australia. J. Fish Dis. 2012;35(3):173–186. doi: 10.1111/j.1365-2761.2011.01332.x. [DOI] [PubMed] [Google Scholar]
- 8.Evans J.J., Klesius P.H., Gilbert P.M., Shoemaker C.A., Al Sarawi M.A., Landsberg J., Duremdez R., Al Marzouk A., Al Zenki S. Characterization of beta-haemolytic Group B Streptococcus agalactiae in cultured seabream, Sparus auratus L., and wild mullet, Liza klunzingeri (Day), in Kuwait. J. Fish Dis. 2002;25(9):505–513. [Google Scholar]
- 9.Soto E., Wang R., Wiles J., Baumgartner W., Green C., Plumb J., Hawke J. Characterization of isolates of Streptococcus agalactiae from diseased farmed and wild marine fish from the U.S. Gulf Coast, Latin America, and Thailand. J. Aquat. Anim. Health. 2015;27(2):123–134. doi: 10.1080/08997659.2015.1032439. [DOI] [PubMed] [Google Scholar]
- 10.Bowater R.O., Dennis M.M., Blyde D., Stone B., Barnes A.C., Delamare-Deboutteville J., Horton M.A., White M., Condon K., Jones R. Epizootics of Streptococcus agalactiae infection in captive rays from Queensland, Australia. J. Fish Dis. 2018;41(2):223–232. doi: 10.1111/jfd.12701. [DOI] [PubMed] [Google Scholar]
- 11.Morick D., Davidovich N., Bigal E., Rosenbluth E., Bouznach A., Rokney A., Ron M., Wosnick N., Tchernov D., Scheinin A.P. Fatal infection in a wild sandbar shark (Carcharhinus plumbeus), caused by Streptococcus agalactiae, Type Ia-ST7. Animals. 2020;10(2):284. doi: 10.3390/ani10020284. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Amborski R.L., Snider T.G., Thune R.L., Culley D.D., Jr. A non-hemolytic, group B Streptococcus infection of cultured bullfrogs, Rana catesbeiana, in Brazil. J. Wildl. Dis. 1983;19(3):180–184. doi: 10.7589/0090-3558-19.3.180. 3rd. [DOI] [PubMed] [Google Scholar]
- 13.Baker C.J. Group B streptococcal infections. Clin. Perinatol. 1997;24(1):59–70. [PubMed] [Google Scholar]
- 14.Evans J.J., Pasnik D.J., Klesius P.H., Al-Ablani S. First report of Streptococcus agalactiae and Lactococcus garvieae from a wild bottlenose dolphin (TURSIOPS TRUNCATUS) J. Wildl. Dis. 2006;42(3):561–569. doi: 10.7589/0090-3558-42.3.561. [DOI] [PubMed] [Google Scholar]
- 15.Zappulli V., Mazzariol S., Cavicchioli L., Petterino C., Bargelloni L., Castagnaro M. Fatal necrotizing fasciitis and myositis in a captive common bottlenose dolphin (Tursiops Truncatus) associated with Streptococcus Agalactiae. J. Vet. Diagn. Invest. 2005;17(6):617–622. doi: 10.1177/104063870501700620. [DOI] [PubMed] [Google Scholar]
- 16.Bonar C.J., Wagner R.A. A third report of “golf ball disease” in an Amazon River dolphin (Inia geoffrensis) associated with Streptococcus iniae. J. Zoo Wildlife Med. 2003;34(3):296–301. doi: 10.1638/1042-7260(2003)034[0296:ATROGB]2.0.CO;2. [DOI] [PubMed] [Google Scholar]
- 17.Bromage E., Owens L. Infection of barramundi Lates calcarifer with Streptococcus iniae: effects of different routes of exposure. Dis. Aquat. Organ. 2002;52:199–205. doi: 10.3354/dao052199. [DOI] [PubMed] [Google Scholar]
- 18.Evans J.J., Klesius P.H., Pasnik D.J., Bohnsack J.F. HumanStreptococcus agalactiaeIsolate in Nile Tilapia (Oreochromis niloticus) Emerg. Infect. Dis. 2009;15(5):774–776. doi: 10.3201/eid1505.080222. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Evans J.J., Bohnsack J.F., Klesius P.H., Whiting A.A., Garcia J.C., Shoemaker C.A., Takahashi S. Phylogenetic relationships among Streptococcus agalactiae isolated from piscine, dolphin, bovine and human sources: a dolphin and piscine lineage associated with a fish epidemic in Kuwait is also associated with human neonatal infections in Japan. J. Med. Microbiol. 2008;57(11):1369–1376. doi: 10.1099/jmm.0.47815-0. [DOI] [PubMed] [Google Scholar]
- 20.Roskar G., McCallister M.P., Ajemian M.J. Performance of two survey gears targeting elasmobranchs in a shallow, subtropical estuary. Mar. Coast. Fisheries. 2020;12(1):50–63. [Google Scholar]
- 21.Bossart G.D., Romano T.A., Peden-Adams M.M., Schaefer A., McCulloch S., Goldstein J.D., Rice C.D., Saliki J.T., Fair P.A., Reif J.S. Clinicoimmunopathologic findings in Atlantic bottlenose dolphins Tursiops truncatus with positive cetacean morbillivirus antibody titers. Dis. Aquat. Organ. 2011;97(2):103–112. doi: 10.3354/dao02410. [DOI] [PubMed] [Google Scholar]
- 22.Bossart G.D., Romano T.A., Peden-Adams M.M., Rice C.D., Fair P.A., Goldstein J.D., Kilpatrick D., Cammen K., Reif J.S. Hematological, biochemical, and immunological findings in Atlantic Bottlenose Dolphins (<I>Tursiops truncatus</I>) with Orogenital Papillomas. Aquat. Mammals. 2008;34(2):166–177. [Google Scholar]
- 23.Fair P.A., Romano T.A., Reif J.S., Schaefer A.M., Hulsey T.C., Bossart G.B., Adams J., Houde M., Muir D.C., Rice C., Peden-Adams M. Association between plasma concentrations of perfluorochemicals (PFCs) and immune and clinical chemistry parameters in bottlenose dolphins (Tursiops truncatus) Environ. Toxicol. Chem. 2013;9999(12):1–12. doi: 10.1002/etc.2122. [DOI] [PubMed] [Google Scholar]
- 24.Bossart G.D., Romano T.A., Peden-Adams M.M., Schaefer A.M., Rice C.D., Fair P.A., Reif J.S. Comparative innate and adaptive immune responses in Atlantic Bottlenose Dolphins (Tursiops truncatus) with viral, bacterial, and fungal infections. Front. Immunol. 2019;10:1125. doi: 10.3389/fimmu.2019.01125. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Beck B.M., Rice C.D. Serum antibody levels against select bacterial pathogens in Atlantic bottlenose dolphins, Tursiops truncatus, from Beaufort NC USA and Charleston Harbor, Charleston, SC, USA. Mar. Environ. Res. 2003;55(2):161–179. doi: 10.1016/s0141-1136(02)00274-x. [DOI] [PubMed] [Google Scholar]
- 26.Fair P.A., Schaefer A.M., Houser D.S., Bossart G.D., Romano T.A., Champagne C.D., Stott J.L., Rice C.D., White N., Reif J.S. The environment as a driver of immune and endocrine responses in dolphins (Tursiops truncatus) PLoS One. 2017;12(5) doi: 10.1371/journal.pone.0176202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Rodgers M.L., Rice C.D. Monoclonal antibodies against loggerhead sea turtle, Caretta caretta, IgY isoforms reveal differential contributions to antibody titers and relatedness among other sea turtles. Dev. Compar. Immunol. 2018;87:12–15. doi: 10.1016/j.dci.2018.05.015. [DOI] [PubMed] [Google Scholar]
- 28.Greene W., Chan B., Bromage E., Grose J.H., Walsh C., Kortright K., Forrest S., Perry G., Byrd L., Stamper M.A. The use of bacteriophages and immunological monitoring for the treatment of a case of chronic septicemic cutaneous ulcerative disease in a loggerhead sea turtle Caretta caretta. J. Aquat. Anim. Health. 2021 doi: 10.1002/aah.10130. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Rodgers M.L., Toline C.A., Rice C.D. Humoral immune responses to select marine bacteria in loggerhead sea turtles Caretta caretta and Kemp’s Ridley sea turtles Lepidochelys kempii from the Southeastern United States. J. Aquat. Anim. Health. 2018;1:20–30. doi: 10.1002/aah.10012. [DOI] [PubMed] [Google Scholar]
- 30.Karsten A.H., Rice C.D. Serum IgM levels against select marine bacteria in the Atlantic sharpnose shark (Rhizoprionodon terraenovae) from three estuaries. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2006;143(3):355–361. doi: 10.1016/j.cbpc.2006.04.011. [DOI] [PubMed] [Google Scholar]
- 31.Bromage E.S., Ye J., Owens L., Kaattari I.M., Kaattari S.L. Use of staphylococcal protein A in the analysis of teleost immunoglobulin structural diversity. Dev. Comp. Immunol. 2004;28(7-8):803–814. doi: 10.1016/j.dci.2003.12.001. [DOI] [PubMed] [Google Scholar]
- 32.Shin G., Lee H., Palaksha K.J., Kim Y., Lee E., Shin Y., Lee E., Park K., Jung T. Production of monoclonal antibodies against serum immunoglobulins of black rockfish (Sebastes schlegeli Higendorf) J. Vet. Sci. 2006;7(3):293–295. doi: 10.4142/jvs.2006.7.3.293. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Margiotta A.L., Bain L.J., Rice C.D. Expression of the major vault protein (MVP) and cellular vault particles in fish. Anat. Rec. 2017;300(11):1981–1992. doi: 10.1002/ar.23645. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Rice C.D., Schlenk D., Ainsworth J., Goksøyr A. Cross-reactivity of monoclonal antibodies against peptide 277–294 of rainbow trout CYP1A1 with hepatic CYP1A among fish. Mar. Environ. Res. 1998;46(1–5):87–91. [Google Scholar]
- 35.Dooley H., Flajnik M.F. Shark immunity bites back: affinity maturation and memory response in the nurse shark, Ginglymostoma cirratum. Eur. J. Immunol. 2005;35(3):936–945. doi: 10.1002/eji.200425760. [DOI] [PubMed] [Google Scholar]
- 36.Dooley H., Flajnik M.F. Antibody repertoire development in cartilaginous fish. Dev. Compar. Immunol. 2006;30(1):43–56. doi: 10.1016/j.dci.2005.06.022. [DOI] [PubMed] [Google Scholar]
- 37.Smith L.E., Crouch K., Cao W., Müller M.R., Wu L., Steven J., Lee M., Liang M., Flajnik M.F., Shih H.H., Barelle C.J., Paulsen J., Gill D.S., Dooley H. Characterization of the immunoglobulin repertoire of the spiny dogfish (Squalus acanthias) Dev. Comp. Immunol. 2012;36(4):665–679. doi: 10.1016/j.dci.2011.10.007. [DOI] [PubMed] [Google Scholar]
- 38.Waterstrat P.R., Brazil J., Ainsworth A.J. Use of an ELISA-based assay for the detection of antibody-secreting cells in channel catfish, Ictalurus punctatus (Rafinesque) J. Fish Dis. 1991;14(6):669–675. [Google Scholar]
- 39.M.R. Arkoosh, S.L. Kaatari, Quantitation of fish antibody to a specific antigen by an enzyme-linked immunosorbent assay (ELISA). in: T.C.F. J.S. Stolen, D.P. Anderson, B.S. Roberson, W.B. van Muiswinkel (Ed.), Techniques in Fish Immunology, SOS Publications, Fairhaven, NJ USA, 1990, pp. 15-24.
- 40.Ye J., Kaattari I.M., Kaattari S.L. The differential dynamics of antibody subpopulation expression during affinity maturation in a teleost. Fish Shellfish Immunol. 2011;30(1):372–377. doi: 10.1016/j.fsi.2010.11.013. [DOI] [PubMed] [Google Scholar]
- 41.Smith N.C., Rise M.L., Christian S.L. A Comparison of the innate and adaptive immune systems in cartilaginous fish, ray-finned fish, and lobe-finned fish. Front. Immunol. 2019;10:2292. doi: 10.3389/fimmu.2019.02292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Sun Y., Huang T., Hammarström L., Zhao Y. The immunoglobulins: new insights, implications, and applications. Ann. Rev. Anim. Biosci. 2020;8(1):145–169. doi: 10.1146/annurev-animal-021419-083720. [DOI] [PubMed] [Google Scholar]
- 43.Criscitiello M.F., Flajnik M.F. Four primordial immunoglobulin light chain isotypes, including lambda and kappa, identified in the most primitive living jawed vertebrates. Eur. J. Immunol. 2007;37(10):2683–2694. doi: 10.1002/eji.200737263. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Work T.M., Dagenais J., Breeden R., Schneemann A., Sung J., Hew B., Balazs G.H., Berestecky J.M. Green turtles (Chelonia mydas) have novel asymmetrical antibodies. J. Immunol. 2015;195(11):5452–5460. doi: 10.4049/jimmunol.1501332. [DOI] [PubMed] [Google Scholar]
- 45.Nollens H.H., Green L.G., Duke D., Walsh M.T., Chittick B., Gearhart S., Klein P.A., Jacobson E.R. Development and validation of monoclonal and polyclonal antibodies for the detection of immunoglobulin G of bottlenose dolphins (Tursiops truncatus) J. Vet. Diagn. Invest. 2007;19(5):465–470. doi: 10.1177/104063870701900502. [DOI] [PubMed] [Google Scholar]
- 46.Nollens H.H., Ruiz C., Walsh M.T., Gulland F.M.D., Bossart G., Jensen E.D., McBain J.F., Wellehan J.F.X. Cross-reactivity between immunoglobulin G antibodies of whales and dolphins correlates with evolutionary distance. Clin. Vaccine Immunol. 2008;15(10):1547. doi: 10.1128/CVI.00219-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Bienfang P.K., Defelice S.V., Laws E.A., Brand L.E., Bidigare R.R., Christensen S., Trapido-Rosenthal H., Hemscheidt T.K., McGillicuddy D.J., Anderson D.M., Solo-Gabriele H.M., Boehm A.B., Backer L.C. Prominent human health impacts from several marine microbes: history, ecology, and public health implications. Int. J. Microbiol. 2011;2011 doi: 10.1155/2011/152815. 152815-152815. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Dyble J., Bienfang P., Dusek E., Hitchcock G., Holland F., Laws E., Lerczak J., McGillicuddy D.J., Minnett P., Moore S.K., O'Kelly C., Solo-Gabriele H., Wang J.D. Environmental controls, oceanography and population dynamics of pathogens and harmful algal blooms: connecting sources to human exposure. Environ. Health. 2008;7(2):S5. doi: 10.1186/1476-069X-7-S2-S5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49.Kemp W.M., Boynton W.R., Adolf J.E., Boesch D.F., Boicourt W.C., Brush G., Cornwell J.C., Fisher T.R., Glibert P.M., Hagy J.D., Harding L.W., Houde E.D., Kimmel D.G., Miller W.D., Newell R.I.E., Roman M.R., Smith E.M., Stevenson J.C. Eutrophication of Chesapeake Bay: historical trends and ecological interactions. Marine Ecol. Progr. Ser. 2005;303:1–29. [Google Scholar]
- 50.Knap A., Dewailly E., Furgal C., Galvin J., Baden D., Bowen R.E., Depledge M., Duguay L., Fleming L.E., Ford T., Moser F., Owen R., Suk W.A., Unluata U. Indicators of ocean health and human health: developing a research and monitoring framework. Environ. Health Perspect. 2002;110(9):839–845. doi: 10.1289/ehp.02110839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Bowen R.E., Depledge M.H. Rapid assessment of marine pollution (RAMP) Mar. Pollut. Bull. 2006;53(10):631–639. doi: 10.1016/j.marpolbul.2006.09.002. [DOI] [PubMed] [Google Scholar]
- 52.Koelmans A.A., Gouin T., Thompson R., Wallace N., Arthur C. Plastics in the marine environment. Environ. Toxicol. Chem. 2014;33(1):5–10. doi: 10.1002/etc.2426. [DOI] [PubMed] [Google Scholar]
- 53.Shuval H. Estimating the global burden of thalassogenic diseases: human infectious diseases caused by wastewater pollution of the marine environment. J. Water Health. 2003;1(2):53–64. [PubMed] [Google Scholar]



